Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
6,937 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00246571 | Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer | completed | Phase 2 | 217 | PfizerINDUSTRY | 12 | Jul 12, 2012 | clinicaltrials |
| NCT00802555 | Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC) | completed | Phase 1 | 21 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 3 | Jul 12, 2012 |
| clinicaltrials |
| NCT00003267 | Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer | completed | Phase 3 | 214 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Jul 11, 2012 | clinicaltrials |
| NCT00523159 | IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable Disease(IMA901-202) | completed | Phase 2 | 68 | Immatics Biotechnologies GmbHINDUSTRY | 10 | Jul 10, 2012 | clinicaltrials |
| NCT00002555 | High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer | completed | Phase 3 | 338 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Jul 2, 2012 | clinicaltrials |
| NCT00002899 | Adjuvant Radiation Therapy in Treating Patients With Brain Metastases | terminated | Phase 3 | 340 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Jul 2, 2012 | clinicaltrials |
| NCT00002903 | Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer | completed | Phase 2 | 25 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Jul 2, 2012 | clinicaltrials |
| NCT00002904 | Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors | completed | Phase 1 | 40 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Jul 2, 2012 | clinicaltrials |
| NCT00003028 | MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 5 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Jul 2, 2012 | clinicaltrials |
| NCT00257205 | CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy | completed | Phase 3 | 655 | AstraZenecaINDUSTRY | 21 | Jul 2, 2012 | clinicaltrials |
| NCT00076024 | AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 174 | PfizerINDUSTRY | 8 | Jun 26, 2012 | clinicaltrials |
| NCT00435409 | A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer | completed | Phase 3 | 442 | PfizerINDUSTRY | 18 | Jun 26, 2012 | clinicaltrials |
| NCT00312845 | Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma | completed | Phase 3 | 676 | Millennium Pharmaceuticals, Inc.INDUSTRY | 32 | Jun 25, 2012 | clinicaltrials |
| NCT00373113 | A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine | terminated | Phase 3 | 482 | PfizerINDUSTRY | 23 | Jun 25, 2012 | clinicaltrials |
| NCT01290406 | BEZ235 Trial in Patients With Advanced Endometrial Carcinoma | withdrawn | Phase 2 | 0 | Novartis PharmaceuticalsINDUSTRY | 12 | Jun 21, 2012 | clinicaltrials |
| NCT00367679 | Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer | completed | Phase 2 | 35 | GlaxoSmithKlineINDUSTRY | 3 | Jun 12, 2012 | clinicaltrials |
| NCT00471328 | Efficacy and Safety of Nilotinib (AMN107) Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib(ENEST) | completed | Phase 3 | 248 | Novartis PharmaceuticalsINDUSTRY | 13 | Jun 12, 2012 | clinicaltrials |
| NCT00311896 | Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT) | terminated | Phase 3 | 402 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 2 | Jun 8, 2012 | clinicaltrials |
| NCT00324558 | Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY) | terminated | Phase 2 | 39 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Jun 8, 2012 | clinicaltrials |
| NCT01008358 | Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma | completed | Phase 2 | 20 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Jun 8, 2012 | clinicaltrials |
| NCT00048659 | YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy | terminated | Phase 2 | — | Astellas Pharma IncINDUSTRY | 10 | Jun 7, 2012 | clinicaltrials |
| NCT00050297 | YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer | terminated | Phase 2 | — | Astellas Pharma IncINDUSTRY | 7 | Jun 7, 2012 | clinicaltrials |
| NCT00254579 | Study of CP-675,206 in Refractory Melanoma | completed | Phase 2 | 251 | AstraZenecaINDUSTRY | 9 | Jun 7, 2012 | clinicaltrials |
| NCT00241449 | A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer | completed | Phase 3 | 51 | AstraZenecaINDUSTRY | 26 | Jun 6, 2012 | clinicaltrials |
| NCT01204996 | A Study of the Safety and Efficacy of CNTO 888 in Combination With SoC (Standard of Care) Chemotherapy in Patients With Solid Tumors | completed | Phase 1 | 53 | Centocor, Inc.INDUSTRY | 2 | May 30, 2012 | clinicaltrials |
| NCT00420849 | A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma | completed | Phase 3 | 587 | Celgene CorporationINDUSTRY | 5 | May 21, 2012 | clinicaltrials |
| NCT00261703 | Docetaxel in Head and Neck Cancer | completed | Phase 2 / Phase 3 | 439 | SanofiINDUSTRY | 2 | May 11, 2012 | clinicaltrials |
| NCT00867750 | SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular Carcinoma(SIRTACE) | completed | Phase 2 | 28 | Sirtex MedicalINDUSTRY | 2 | May 7, 2012 | clinicaltrials |
| NCT00404495 | Combination of Irinotecan and Temozolomide in Children With Brain Tumors. | completed | Phase 2 | 83 | PfizerINDUSTRY | 8 | Apr 18, 2012 | clinicaltrials |
| NCT00420927 | Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis(OPTIMA) | completed | Phase 4 | 1,032 | AbbottINDUSTRY | 21 | Apr 18, 2012 | clinicaltrials |
| NCT00171340 | Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. | completed | Phase 3 | 1,065 | Novartis PharmaceuticalsINDUSTRY | 28 | Apr 16, 2012 | clinicaltrials |
| NCT00969410 | A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases | completed | Phase 1 | 19 | AVEO Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 12, 2012 | clinicaltrials |
| NCT00171314 | The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer | completed | Phase 3 | 527 | Novartis PharmaceuticalsINDUSTRY | 9 | Apr 11, 2012 | clinicaltrials |
| NCT00454649 | Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor | completed | Phase 1 | 102 | PfizerINDUSTRY | 3 | Apr 4, 2012 | clinicaltrials |
| NCT00499265 | Gemcitabine With or Without WX-671 in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 95 | Heidelberg Pharma AGINDUSTRY | 6 | Mar 29, 2012 | clinicaltrials |
| NCT01394120 | Chemotherapy Selection Based on Therapeutic Targets for Advanced Pancreatic Cancer | unknown | Phase 2 | 60 | Sofia Perea, Director Clinical Trials Unit.OTHER | 1 | Mar 27, 2012 | clinicaltrials |
| NCT00149214 | Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens | completed | Phase 2 | 257 | Eli Lilly and CompanyINDUSTRY | 4 | Mar 21, 2012 | clinicaltrials |
| NCT00558363 | ARTS - AVODART After Radical Therapy For Prostate Cancer Study(ARTS) | completed | Phase 2 | 294 | GlaxoSmithKlineINDUSTRY | 9 | Mar 21, 2012 | clinicaltrials |
| NCT01102608 | Neoadyuvant High-dose of Ifosfamide and Concurrent Radiotherapy in Soft Tissue Sarcoma | completed | Phase 2 | 32 | Grupo Espanol de Investigacion en SarcomasOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00721747 | Taxotere®, Followed by Myocet® and Cyclophosphamide First Line Treatment in HER2 Neg Breast Cancer | unknown | Phase 2 | 83 | Grupo Oncológico GallegoOTHER | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00094029 | A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248 | approved for marketing | — | — | PfizerINDUSTRY | 34 | Mar 9, 2012 | clinicaltrials |
| NCT00130897 | Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma | approved for marketing | — | — | PfizerINDUSTRY | 50 | Mar 9, 2012 | clinicaltrials |
| NCT01549782 | Mixture of Prebiotics on Intestinal Microbiota of Patients Receiving Abdominal Radiotherapy. | completed | N/A | 40 | Hospital General Universitario Gregorio MarañonOTHER | 1 | Mar 9, 2012 | clinicaltrials |
| NCT01548170 | To Assess the Interaction Between Sunitinib and Ketoconazole to Reduce the Dose and Cost of Sunitinib | completed | Phase 1 | 12 | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalOTHER | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00003279 | Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer(SILVA) | completed | Phase 3 | 500 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Mar 6, 2012 | clinicaltrials |
| NCT00003589 | Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 3 | 450 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Mar 6, 2012 | clinicaltrials |
| NCT00003643 | Combination Chemotherapy in Treating Men With Germ Cell Cancer | unknown | Phase 2 / Phase 3 | 498 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Mar 6, 2012 | clinicaltrials |
| NCT00101660 | Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib | completed | Phase 2 | 387 | Bristol-Myers SquibbINDUSTRY | 22 | Mar 2, 2012 | clinicaltrials |
| NCT00813072 | Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma | completed | Phase 2 | 135 | PharmaEngineINDUSTRY | 6 | Mar 2, 2012 | clinicaltrials |
| NCT00336791 | Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer | completed | Phase 3 | 273 | M.D. Anderson Cancer CenterOTHER | 4 | Feb 14, 2012 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials